First patient recruited to InterAACT study

Amitesh Roy_thumbnail

The first Australian patient has been randomised to the InterAACT study. This patient was from Austin Hospital (PI: A/Prof Niall Tebbutt) and was randomised 4th January 2017. More patients are needed so referrals are welcome. InterAACT is an international, multicentre trial aiming to establish which chemotherapy regimen is more effective … Read More

Immogen does it again


How many 14 year olds do you know that spend their time raising funds and awareness for cancer charities?   How many are committed to making cancer a disease of the past? Brighton local Immogen Newcombe-Bennion is an exceptional young woman and someone her classmates can look up to. In … Read More

Advanced GIST Study – many lives changed


An article by Professor John Zalcberg OAM The impending closure of the Advanced GIST Study, a randomised phase III international study of imatinib in metastatic or locally advanced gastrointestinal stromal tumours (GIST), reflects a critical milestone in the management of this disease.   The AGITG was fortunate to be involved … Read More

Genesis of a clinical trial

Dr Kashraw and Luke Garrick

To establish a clinical trial and successfully receive funding for academic research takes a considerable amount of effort and time. It requires collaboration across multi-disciplinary teams made up of experts in the fields of medical oncology, surgery, radiation oncology, biological research, quality of life research, statistics, study coordination and consumer … Read More

I’m lucky to be here


Jason Kuenz is a house painter in Kallangur, QLD and loves to keep himself busy. Ever since he was diagnosed with stomach cancer in 2012 and again in 2013, he has been determined to do as many things as possible with his life. “I was going to my GP in … Read More